|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.6 SEK | +2.05% |
|
+3.44% | +0.22% |
Infant Bacterial Therapeutics AB (publ) announced that Maria Ekdahl has been appointed Chief Financial Officer (CFO) effective September 19, 2022. She will be part of the Management Team and report to Staffan Strömberg, CEO of IBT. Maria, who has a Master's degree in economics from Linnaeus University, comes to IBT from the Swedish Film Institute where she served as CFO.
She brings with her an extensive financial background from organizations including Telenor, Karolinska and Coca-Cola.
| 1st Jan change | Capi. | |
|---|---|---|
| +0.22% | 108M | |
| +4.09% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +21.00% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
INFANT BACTERIAL THERAPEUTICS AB 
